Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who had a CT scan because a kidney tumor was suspected, and the scan showed no signs of kidney cancer
- People diagnosed with clear cell renal cell carcinoma (a specific type of kidney cancer) or oncocytoma (a usually non-cancerous kidney growth) who have had their tumor confirmed through a biopsy or surgical sample
- People who have signed a consent form agreeing to take part
- People who are able to follow and complete the procedures required by the trial
Who may not be able to join:
- People diagnosed with a type of kidney cancer that is not clear cell renal cell carcinoma (other subtypes of kidney cancer)
- People whose kidney cancer has a feature called pure sarcomatoid differentiation, sometimes referred to as sarcoma of the kidney
- People currently using a blood-thinning medication called heparin to treat an ongoing condition such as a blood clot in a vein or in the lungs — note that short-term use of heparin to prevent clots around the time of surgery (up to 4 weeks after surgery) may still be permitted (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To identify the optimal GAG score; To identify the optimal GAG score; To identify the optimal GAG score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.